Saba Capital Management, L.P. sold HQL
September 22, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 41,623 shares of Abrdn Life Sciences Investors at $14.14 per share, a transaction worth $588.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
41,623
Price
$14.14
Total value
$588.5K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 22, 2025
Filing dateSeptember 23, 2025
Shares owned after2,837,633
OwnershipIndirect
10b5-1 planNo
AmendedNo